Cargando…
Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival
Introduction: Hypertension is common in patients with severe aortic stenosis undertaking transcatheter aortic valve replacement (TAVR). Renin–angiotensin system (RAS) blockade therapy with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) has recently been a...
Autor principal: | Klinkhammer, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759619/ https://www.ncbi.nlm.nih.gov/pubmed/31579456 http://dx.doi.org/10.15171/jcvtr.2019.30 |
Ejemplares similares
-
The development of transcatheter aortic valve replacement (TAVR)
por: Cribier, Alain
Publicado: (2016) -
Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non‐TAVR Centers
por: Jack, Godly, et al.
Publicado: (2019) -
Transcatheter Aortic Valve Replacement (TAVR) in Thalassemic Patients
por: Mehta, Yatin, et al.
Publicado: (2022) -
Imaging in Transcatheter Aortic Valve Replacement (TAVR): role of the radiologist
por: Litmanovich, Diana E., et al.
Publicado: (2014) -
Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR‐in‐TAVR
por: Nai Fovino, Luca, et al.
Publicado: (2020)